U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07512037) titled 'Burden-Evaluated Active Therapy for AF Using Continuous Wearables BEAT-AF Trial' on March 23.
Brief Summary: Traditional AF classification (e.g., paroxysmal, persistent, permanent) relies largely on patient-reported symptoms and intermittent electrocardiographic monitoring, which cannot continuously or objectively reflect disease progression, nor effectively inform optimal intervention timing. Although "AF burden" (i.e., duration of AF episodes) has emerged as a potential marker, its association with clinical outcomes remains inconsistent due to limitations in monitoring methods and its one-dimensional nature. Based on our previous ...